Literature DB >> 16240472

Erlotinib in lung cancer.

Toshimi Takano, Yuichiro Ohe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16240472

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

Authors:  Guolin Zhang; Bin Fang; Richard Z Liu; Huiyi Lin; Fumi Kinose; Yun Bai; Umut Oguz; Elizabeth R Remily-Wood; Jiannong Li; Soner Altiok; Steven Eschrich; John Koomen; Eric B Haura
Journal:  J Proteome Res       Date:  2010-12-03       Impact factor: 4.466

2.  Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer.

Authors:  Samuel Murray; Vasilios Karavasilis; Mattheos Bobos; Evangelia Razis; Savvas Papadopoulos; Christos Christodoulou; Paris Kosmidis; George Fountzilas
Journal:  J Exp Clin Cancer Res       Date:  2012-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.